understanding today’s medtech landscape for start-ups: PART 1

There is no shortage of challenges facing start-up companies in today’s fast-paced world of MedTech product approval and commercialization. From keeping informed of shifting regulatory requirements to ensuring judicious use of resources, development functions must be aligned with an integrated strategy that considers multiple factors and stakeholders to achieve success.

Join us for Part 1 of our conversation with Marwan Berrada (Advanced NanoTherapies President, CEO and Co-Founder) and Michael Tar (NAMSA Global Consulting Sales Strategist) as we delve into the most pressing issues start-ups encounter, as well as suggested strategies for successful regulatory approval and market introductions.

If you would like to learn more about the benefits of NAMSA’s APEX Program, we invite you to visit: https://namsa.com/services/apex-program/.